Specifically, quantifying the timing between glucose depletion and the onset of ER stress and mitochondrial dysfunction, as well as exploring the molecular mechanisms linking glucose deprivation to ER stress and mitochondrial dysfunction in this context, would enhance our understanding of IL-24’s apoptotic mechanisms and reveal potential targets for synergistic cancer therapies. This evidence concerns the gene IL24 and cancer.